Cytomegalovirus resistance in CD34(+)-selected hematopoietic cell transplant recipients Journal Article


Authors: Kim, S. J.; Huang, Y. T.; Foldi, J.; Lee, Y. J.; Maloy, M.; Giralt, S. A.; Jakubowski, A. A.; Papanicolaou, G. A.
Article Title: Cytomegalovirus resistance in CD34(+)-selected hematopoietic cell transplant recipients
Abstract: Background: Cytomegalovirus (CMV) viremia after CD34+-selected hematopoietic stem cell transplant (HCT) often requires prolonged antiviral therapy. We report rates and outcomes of resistant CMV in a contemporary cohort of CD34+-selected HCT recipients managed preemptively. Methods: We retrospectively reviewed 220 consecutive, CMV-seropositive recipients (R+), who received CD34+-selected HCT at Memorial Sloan Kettering Cancer Center between June 2010 and December 2014. Patients were monitored by quantitative CMV PCR and were treated preemptively. CMV resistance was tested by a genotypic assay. Results: One hundred and sixty-one (73%) patients developed CMV viremia and 47 (29% of viremic and 21% of total patients) had CMV resistance testing by one-year from HCT. CMV resistance was confirmed in 19 (12% of viremic and 9% of total) patients and was identified >3 months from HCT in 90% of patients. Twelve patients had mutations in UL97 only; the remaining 7 patients had mutations in UL54 only or UL54 and UL97. By 1 year from HCT, 11 of 19 (58%) patients with mutations had CMV end-organ disease. CMV-related mortality in patients with resistance was 42%. Conclusions: Nine percent of CMV R+, CD34+-selected HCT recipients had resistant CMV by 1 year from HCT. Of 19 patients with resistant CMV, 58% had CMV end-organ disease and 42% died of CMV. Effective strategies for CMV prevention and restoration of CMV immunity are needed for CD34+-selected HCT. © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Keywords: genotype; hematopoietic stem cell transplantation; cytomegalovirus; resistance; cd34+-selected
Journal Title: Transplant Infectious Disease
Volume: 20
Issue: 3
ISSN: 1398-2273
Publisher: Wiley Blackwell  
Date Published: 2018-06-01
Start Page: e12881
Language: English
DOI: 10.1111/tid.12881
PROVIDER: scopus
PMCID: PMC5988949
PUBMED: 29570237
DOI/URL:
Notes: Article -- Export Date: 2 July 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yeon Joo Lee
    50 Lee
  2. Sergio Andres Giralt
    1050 Giralt
  3. Molly Anna Maloy
    269 Maloy
  4. Yao-Ting Huang
    28 Huang
  5. Julia   Foldi
    4 Foldi
  6. Seong Jin   Kim
    13 Kim